ASI and National Museum of Denmark sign MoU for underwater Archaeological Investigation (See 'Corp Brief') Leyland, Switch Mobility to provide discounts for replacement of old trucks and buses (See 'Corp Brief') MeitY convenes Consultation on 'Supporting AI Transformation of IT Services Industry' (See 'Corp Brief') IPR - Copyright - object of Section 57 is to lift an author's status beyond material gains of copyright & give it special status & put intellectual property on a higher pedestal than normal objects of copyright: HC (See 'Legal Desk') Railways approves Rs.201 Crore Kavach Project for Ambala Division (See 'Corp Brief') IICA hosts National Conference on 'Redefining India's Restructuring Ecosystem' (See 'Corp Brief') Companies Act - Aggregate allotment of shares to 284 persons through 7 issuances demonstrates fund-raising exercise beyond scope of statutory exemption; it constitutes deemed public offer attracting requirements of Companies Act & applicable SEBI regulations: SAT (See 'Legal Desk') PM Modi, Macron inaugurate 'Bharat Innovates 2026' (See 'Corp Brief') Holistic Access to Justice Scheme and 'Reforms Utsav' held in HP (See 'Corp Brief') National Urban Learning Platform launched as urban arm of iGOT-Mission Karmayogi (See 'Corp Brief') CSIR-NIScPR Organized Skill Training Programme on Basics of Koha Software (See 'Corp Brief') PMLA- Forfeiture unsustainable where nexus between property and illegally acquired income not established: SAFEMA (See 'Legal Desk') The Income Tax Act, 2025: Privacy, Power, and Constitutional Scrutiny (See CORP EINSICHT )

Print

Sun Pharma subsidiary to acquire 12.5 per cent stake in Australia-based WRS Bioproducts

Published: Mar 06, 2021

By TIOLCORPLAWS News Service

MUMBAI, MAR 06, 2021: DRUG major Sun Pharmaceuticals said on Friday that its wholly-owned subsidiary will acquire 428,571 ordinary shares, equivalent to 12.5 per cent stake, in Australia-based nutraceutical and food supplements company, WRS Bioproducts.

WRS Bioproducts is an early-stage company that grows diverse algae, harvest, extract and purify high-value ingredients for sale to dietary supplements, food, cosmetic and animal nutrition markets using their own novel technologies.

Sun Pharma will pay AUD 2 million Australian dollars for the 12.5 per cent stake, on a fully diluted basis, and expects to complete the acquisition by March 15.

Sun Pharma is an Indian multinational pharmaceutical company which is the world's fourth largest specialty generic drug manufacturer.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.